AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore
University of Washington School of Medicine / Fred Hutch Cancer Center at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
University of Washington School of Medicine / Fred Hutch Cancer Center brings 2 presentations to AMP 2026 in Seattle, its home city. Its sessions cover biomarker testing in genitourinary cancers, and the part pathologists play in deciding which biomarkers are discovered, selected and used in the clinic. A haematopathology case talk uses long-read sequencing to find a cryptic RARA insertion that confirmed acute promyelocytic leukaemia.
| Organization | AMP 2026 Attendance |
|---|---|
UW University of Washington School of Medicine / Fred Hutch Cancer Center Seattle, WA | |
Seattle medical school and its cancer research and treatment partner, together covering oncology genomics, transplantation and clinical trials. | Workshop Wed, Nov 11 8:00am–8:50am The Precision Pathway: How Pathologists Are Transforming Biomarker Discovery, Selection, and Clinical Impact Across GU Cancers Biomarker selection, specimen handling and reporting for genitourinary cancers, worked through interactive case discussions. |
Find decision makers at University of Washington School of Medicine / Fred Hutch Cancer Center
Tell us what you sell and we’ll find the people at University of Washington School of Medicine / Fred Hutch Cancer Center most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction